infertility
Women's health · 2016–2022
3decisions
2medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| progesterone Luteal phase support as part of an assisted reproductive technology (ART) treatment cycle for infertile women. | Jul 2022 | Recommended with restriction | none received |
| follitropin alfa Assisted Reproductive Technology (Section 100 IVF Program); also listed for anovulatory infertility and hypogonadotrophic hypogonadism on the General Schedule. | Mar 2018 | Recommended with restriction | none received |
| follitropin alfa Treatment of women undergoing assisted reproductive technology (ART), women with anovulatory infertility unresponsive to clomiphene citrate or where clomiphene… | Mar 2016 | Recommended with restriction | input received Access Australia |
Who spoke
Access Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 3 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.